Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Crown

Showing results (81-90 of 202) with videos related to

Pageof 21
Sort By:
Journal of Medicinal Chemistry|May 3, 2012
Structure--activity relationship and mode of action of N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters: novel organometallic anticancer compoundsAine Mooney, Rachel Tiedt, Thamir Maghoub, et al.
Clinical Proteomics|September 13, 2011
The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?Michael J Duffy, Maeve Mullooly, Norma O'Donovan, et al.
International Journal of Cancer|September 8, 2004
Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic studyAnnemarie Larkin, Lorraine O'Driscoll, Susan Kennedy, et al.
Clinical Chemistry|January 17, 2004
High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancerMichael J Duffy, Catherine Duggan, Rachel Keane, et al.
Frontiers in Oncology|March 19, 2014
In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case StudiesMartina McDermott, Alex J Eustace, Steven Busschots, et al.
British Journal of Cancer|July 28, 2020
Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancerNaomi Walsh, Charlotte Andrieu, Peter O'Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Caspase 3 in breast cancerNorma O'Donovan, John Crown, Helen Stunell, et al.
Journal of Proteomics|January 18, 2011
2D-DIGE analysis of phospho-enriched fractions from dasatinib-treated melanoma cell linesAlex J Eustace, Paul Dowling, Michael Henry, et al.
Electrophoresis|November 28, 2007
2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteinsPaul Dowling, Lorraine O'Driscoll, Paula Meleady, et al.
Breast Cancer Research and Treatment|December 31, 2014
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancerMichael R Clemens, Oleg A Gladkov, Elaina Gartner, et al.
Pageof 21

Showing results (81-90 of 202) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|May 3, 2012
Structure--activity relationship and mode of action of N-(6-ferrocenyl-2-naphthoyl) dipeptide ethyl esters: novel organometallic anticancer compoundsAine Mooney, Rachel Tiedt, Thamir Maghoub, et al.
Clinical Proteomics|September 13, 2011
The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?Michael J Duffy, Maeve Mullooly, Norma O'Donovan, et al.
International Journal of Cancer|September 8, 2004
Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic studyAnnemarie Larkin, Lorraine O'Driscoll, Susan Kennedy, et al.
Clinical Chemistry|January 17, 2004
High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancerMichael J Duffy, Catherine Duggan, Rachel Keane, et al.
Frontiers in Oncology|March 19, 2014
In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case StudiesMartina McDermott, Alex J Eustace, Steven Busschots, et al.
British Journal of Cancer|July 28, 2020
Whole-exome sequencing of long-term, never relapse exceptional responders of trastuzumab-treated HER2+ metastatic breast cancerNaomi Walsh, Charlotte Andrieu, Peter O'Donovan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Caspase 3 in breast cancerNorma O'Donovan, John Crown, Helen Stunell, et al.
Journal of Proteomics|January 18, 2011
2D-DIGE analysis of phospho-enriched fractions from dasatinib-treated melanoma cell linesAlex J Eustace, Paul Dowling, Michael Henry, et al.
Electrophoresis|November 28, 2007
2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteinsPaul Dowling, Lorraine O'Driscoll, Paula Meleady, et al.
Breast Cancer Research and Treatment|December 31, 2014
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancerMichael R Clemens, Oleg A Gladkov, Elaina Gartner, et al.
Pageof 21